Nantahala Capital Management, LLC Gossamer Bio, Inc. Transaction History
Nantahala Capital Management, LLC
- $1.5 Billion
- Q2 2024
A detailed history of Nantahala Capital Management, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 672,856 shares of GOSS stock, worth $619,027. This represents 0.04% of its overall portfolio holdings.
Number of Shares
672,856
Previous 672,856
-0.0%
Holding current value
$619,027
Previous $605,000
-0.0%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding GOSS
# of Institutions
101Shares Held
175MCall Options Held
453KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$16.6 Million1.54% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$12.2 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$10.8 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.45 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.41 Million4.25% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $86.4M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...